Ayunova Pharmaceutical LLP

Product Name

Zidovudine + Lamivudine Tablets BP – Fixed Dose Combination

(Common strength: Zidovudine 300 mg + Lamivudine 150 mg)

Product Description

Zidovudine + Lamivudine Tablets BP is a fixed-dose antiretroviral combination used in the treatment and management of HIV-1 infection.

• Zidovudine (AZT) is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits HIV replication by interfering with viral DNA synthesis.

• Lamivudine (3TC) is also an NRTI that enhances antiviral efficacy by blocking the HIV reverse transcriptase enzyme.

This combination is widely used as part of combination antiretroviral therapy (ART) to reduce viral load, improve immune function, and slow disease progression.

Composition

Each film-coated tablet contains:

• Zidovudine BP – 300 mg

• Lamivudine BP – 150 mg

• Excipients: q.s.

Major Indications / Uses Primary Indications

• Treatment of HIV-1 infection in adults and children (as part of combination ART)

Additional / Clinical Uses

• Prevention of mother-to-child transmission (PMTCT) of HIV

• Reduction of HIV viral load

• Improvement of CD4 cell count and immune response

• Management of HIV in resource-limited settings

Dosage & Administration

• Route: Oral

• Usual Dose: As prescribed by the physician (commonly twice daily)

• Administration: Can be taken with or without food

⚠ Regular monitoring of blood counts recommended
⚠ Use under medical supervision only
⚠ Not recommended as monotherapy for HIV

Packaging Details

• Blister strips / HDPE bottles

• Hospital, institutional & export packaging available

Storage Conditions

• Store below 30°C

• Protect from light and moisture

• Keep out of reach of children

Product Name

Rabeprazole + Domperidone Tablets BP
(Proton Pump Inhibitor + Prokinetic / Antiemetic Combination)

Common Strengths:

• Rabeprazole 20 mg (Enteric Coated)

• Domperidone 10 mg (SR / IR)

Product Description

Rabeprazole + Domperidone Tablets BP is a widely prescribed anti-ulcer and anti-reflux combination used in the management of acid-related gastrointestinal disorders accompanied by nausea, vomiting, and delayed gastric emptying.

• Rabeprazole is a proton pump inhibitor that suppresses gastric acid secretion by irreversibly inhibiting the gastric H⁺/K⁺-ATPase enzyme.

• Domperidone enhances gastric motility and provides effective antiemetic action by blocking dopamine (D₂) receptors.

This combination ensures rapid acid suppression, improved gastric emptying, and long-lasting relief from reflux symptoms.

Composition

Each tablet contains:

• Rabeprazole Sodium BP – 20 mg (Enteric Coated)

• Domperidone BP – 10 mg (Sustained Release / Immediate Release)

• Excipients: q.s.

Major Indications / Uses Primary Indications

• Gastroesophageal Reflux Disease (GERD)

• Peptic ulcer disease

• Acid reflux and heartburn

Extended / Big Indications

• Functional and non-ulcer dyspepsia

• Chronic gastritis

• Erosive esophagitis

• Regurgitation and acid indigestion

• Nausea and vomiting due to hyperacidity

• Delayed gastric emptying (gastroparesis)

• Abdominal bloating and epigastric discomfort

• NSAID-induced gastric irritation

• Post-prandial fullness and belching

• Reflux symptoms in diabetic patients

Dosage & Administration

• Route: Oral

• Recommended Dose: One tablet once daily or as directed by physician

• Administration: To be taken before meals, preferably in the morning

⚠ Use under medical supervision
⚠ Long-term use should be monitored

Packaging Details

• Alu-Alu / PVC-Alu blister packs

• Strip, box, and bulk packaging available

• Hospital and export-oriented supply supported

Storage Conditions

• Store below 30°C

• Protect from light and moisture

• Keep out of reach of children

Rocuronium Bromide Injection Product Description

Rocuronium Bromide Injection is a sterile, non-depolarizing neuromuscular blocking agent used to induce skeletal muscle relaxation during surgical procedures or mechanical ventilation. It provides rapid onset of muscle relaxation, facilitating endotracheal intubation and maintenance of anesthesia. This injection is intended for intravenous use under the supervision of trained healthcare professionals in hospitals, surgical centers, and critical care settings.

Composition

• Active Ingredient:
  Rocuronium Bromide – [Specify mg per ml]

• Excipients:
  q.s.

• Dosage Form:
  Sterile injection

Uses / Indications

Rocuronium Bromide Injection is indicated for:

• Muscle relaxation during general anesthesia

• Facilitation of endotracheal intubation

• Maintenance of skeletal muscle relaxation during mechanical ventilation

• As prescribed by an anesthesiologist or trained clinician

(Prescription medicine – hospital and clinical use only)

Dosage & Administration

• Administered intravenously by trained healthcare professionals

• Dosage depends on patient age, weight, and clinical condition

• Neuromuscular function and vital signs should be monitored during administration

Storage Instructions

• Store below 25°C

• Protect from light

• Keep the vial tightly closed

• Keep out of reach of children

Precautions & Warnings

• For prescription use only

• Use with caution in patients with hepatic, renal, or neuromuscular disorders

• Monitor respiratory and cardiovascular status during administration

• Not recommended during pregnancy unless clearly indicated

Packaging Details

• Vial containing [specify volume and strength]

• Supplied with protective outer carton

Quality Standards

• Manufactured in compliance with IP and GMP guidelines

• Tested for sterility, potency, and safety

Country of Origin

• India

Propofol Injection 100 mg / 10 ml Product Description

Propofol Injection 100 mg / 10 ml is a sterile intravenous anesthetic agent used for the induction and maintenance of general anesthesia and sedation. It offers rapid onset and fast recovery, making it suitable for surgical procedures, intensive care sedation, and outpatient anesthesia. The injection is intended for intravenous administration under the supervision of trained healthcare professionals.

Composition

• Active Ingredient:
  Propofol – 100 mg / 10 ml (10 mg/ml)

• Excipients:
  Soybean oil, glycerol, egg lecithin, sodium hydroxide, water for injection

• Dosage Form:
  Sterile injectable emulsion

Uses / Indications

Propofol Injection is indicated for:

• Induction of general anesthesia

• Maintenance of anesthesia during surgical procedures

• Sedation of mechanically ventilated patients in intensive care units

• Procedural sedation in minor surgical or diagnostic procedures

(Prescription medicine – hospital and clinical use only)

Dosage & Administration

• Administered intravenously by trained healthcare professionals

• Dosage depends on patient age, weight, clinical condition, and procedure

• Continuous monitoring of respiratory and cardiovascular status is required

• Not for intramuscular use

Storage Instructions

• Store below 25°C

• Protect from light and heat

• Keep the vial tightly closed

• Keep out of reach of children

Precautions & Warnings

• For prescription use only

• Use with caution in patients with cardiac, respiratory, or hepatic impairment

• Monitor vital signs continuously during administration

• Not recommended during pregnancy unless clearly indicated

Packaging Details

• 10 ml vial containing 100 mg Propofol

• Supplied with protective outer carton

Quality Standards

• Manufactured in compliance with IP and GMP guidelines

• Tested for sterility, potency, and safety

Country of Origin

• India

LEFVAZ 20 Tablets – 10’s Product Description

LEFVAZ 20 Tablets contain Leflunomide 20 mg, a disease-modifying antirheumatic drug (DMARD) used in the treatment of autoimmune and inflammatory conditions, particularly rheumatoid arthritis. Leflunomide works by inhibiting pyrimidine synthesis, which reduces immune system overactivity, helps control inflammation, and slows disease progression. This medicine should be used strictly under medical supervision.

Composition

• Active Ingredient:
  Leflunomide – 20 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Film-coated tablet

• Pharmacopoeial Standard:
  IP

Uses / Indications

LEFVAZ 20 Tablets are indicated for:

• Active rheumatoid arthritis

• Autoimmune inflammatory disorders as prescribed by a physician

(Prescription medicine – use only under medical supervision)

Dosage & Administration

• Dosage as prescribed by the treating physician

• Taken orally, with or without food

• Tablets should be swallowed whole with water

• Regular monitoring of liver function and blood counts is advised

Storage Instructions

• Store below 30°C

• Protect from moisture and sunlight

• Keep out of reach of children

Cabolong 40 mg Tablets – Cabozantinib Product Description

Cabolong Tablets contain Cabozantinib 40 mg, an oral tyrosine kinase inhibitor (TKI) used in the treatment of certain cancers. Cabozantinib works by inhibiting multiple receptor tyrosine kinases involved in tumor growth, angiogenesis, and metastasis. It is prescribed for advanced renal cell carcinoma, hepatocellular carcinoma, and other malignancies as per physician guidance. Cabolong Tablets should be used strictly under oncologist supervision.

Composition

• Active Ingredient:
  Cabozantinib – 40 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Film-coated tablets

• Pharmacopoeial Standard:
  IP / USP (as applicable)

Uses / Indications

Cabolong 40 mg Tablets are indicated for:

• Advanced renal cell carcinoma (RCC)

• Hepatocellular carcinoma (HCC)

• Thyroid carcinoma and other malignancies (as prescribed)

• Used under the supervision of an oncologist

(Prescription medicine – oncology use only)

Dosage & Administration

• Take orally as directed by the treating oncologist

• Usually taken once daily with or without food

• Swallow tablets whole; do not crush or chew

• Dosage may be adjusted based on patient tolerance and side effects

Storage Instructions

• Store below 30°C

• Protect from moisture and direct sunlight

• Keep out of reach of children

Rebopag – Eltrombopag Tablets 50 mg Product Description

Rebopag Tablets contain Eltrombopag 50 mg, an oral thrombopoietin receptor agonist used to increase platelet production in patients with thrombocytopenia. Eltrombopag binds to the thrombopoietin receptor on bone marrow megakaryocytes, stimulating platelet production and helping reduce the risk of bleeding. Rebopag should be used under the supervision of a hematologist or treating physician.

Composition

• Active Ingredient:
  Eltrombopag – 50 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Film-coated tablet

• Pharmacopoeial Standard:
  IP / USP

Uses / Indications

Rebopag Tablets are indicated for:

• Thrombocytopenia in chronic immune thrombocytopenic purpura (ITP)

• Thrombocytopenia in patients with chronic hepatitis C infection to allow antiviral therapy

• Other conditions causing low platelet counts as prescribed by a physician

(Prescription medicine – hospital and specialty use only)

Dosage & Administration

• Take orally as prescribed by the physician

• Usually taken on an empty stomach or 2 hours before/after food containing divalent cations (e.g., dairy, antacids)

• Swallow tablets whole with water

• Regular monitoring of platelet counts, liver function, and other blood parameters is recommended

Storage Instructions

• Store below 30°C

• Protect from moisture and sunlight

• Keep out of reach of children

Sulfasalazine Delayed Release Tablets 1000 mg Product Description

Sulfasalazine Delayed Release Tablets 1000 mg are anti-inflammatory and immunomodulatory medications used primarily in the management of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease, and in certain types of arthritis. The delayed-release formulation ensures the active ingredient is released in the intestine rather than the stomach, enhancing efficacy and minimizing gastric irritation.

Composition

• Active Ingredient:
  Sulfasalazine – 1000 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Delayed-release tablet

• Pharmacopoeial Standard:
  IP / USP

Uses / Indications

Sulfasalazine 1000 mg Tablets are indicated for:

• Ulcerative colitis

• Crohn’s disease

• Rheumatoid arthritis and other inflammatory conditions as prescribed by a physician

(Prescription medicine – hospital and pharmacy use only)

Dosage & Administration

• Take orally as directed by the physician

• Swallow tablets whole with water; do not crush or chew

• Dosage depends on patient age, weight, and clinical condition

• Regular monitoring of blood counts, liver, and kidney function is recommended during prolonged therapy

Storage Instructions

• Store below 30°C

• Protect from moisture and direct sunlight

• Keep out of reach of children

METHORA – Methotrexate Tablets IP 20 mg Product Description

METHORA Tablets contain Methotrexate 20 mg, an antimetabolite and immunosuppressant medicine used in the management of autoimmune disorders and certain malignancies. Methotrexate acts by inhibiting dihydrofolate reductase, thereby suppressing abnormal cell growth and excessive immune response. Due to its potent nature and narrow therapeutic index, METHORA Tablets must be used strictly under medical supervision.

Composition

• Active Ingredient:
  Methotrexate IP – 20 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Tablet

• Pharmacopoeial Standard:
  IP

Uses / Indications

METHORA Methotrexate Tablets are indicated for:

• Rheumatoid arthritis and other autoimmune disorders

• Moderate to severe psoriasis

• Certain malignancies such as leukemia and lymphomas

• Other conditions as prescribed by the physician

(Prescription medicine – use only under medical supervision)

Dosage & Administration

• Administered orally as prescribed by the physician

• Generally taken once weekly for non-oncological conditions

• Tablets should be swallowed whole with water

• Regular monitoring of blood counts, liver function, and renal function is essential

Storage Instructions

• Store below 25°C

• Protect from moisture and light

• Keep out of reach of children

METHORA – Methotrexate Tablets IP 25 mg Product Description

METHORA Tablets contain Methotrexate 25 mg, an antimetabolite and immunosuppressant medication used in the treatment of autoimmune disorders and certain cancers. Methotrexate works by inhibiting dihydrofolate reductase, leading to reduced abnormal cell proliferation and immune suppression. Due to its narrow therapeutic index, METHORA Tablets should be used strictly under the supervision of a qualified physician.

Composition

• Active Ingredient:
  Methotrexate IP – 25 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Tablet

• Pharmacopoeial Standard:
  IP

Uses / Indications

METHORA Methotrexate Tablets are indicated for:

• Rheumatoid arthritis and other autoimmune disorders

• Moderate to severe psoriasis

• Certain malignancies such as leukemia and lymphomas

• Other conditions as prescribed by the physician

(Prescription medicine – use under strict medical supervision)

Dosage & Administration

• Taken orally as directed by the physician

• Typically administered once weekly for non-oncological indications

• Tablets should be swallowed whole with water

• Regular monitoring of blood counts, liver, and kidney function is mandatory

Storage Instructions

• Store below 25°C

• Protect from moisture and light

• Keep out of reach of children

METHORA – Methotrexate Tablets IP 15 mg Product Description

METHORA Tablets contain Methotrexate 15 mg, an antimetabolite and immunosuppressant medication used in the treatment of autoimmune disorders and certain cancers. Methotrexate works by inhibiting dihydrofolate reductase, leading to suppression of abnormal cell growth and immune activity. Due to its narrow therapeutic index, METHORA Tablets must be used strictly under the supervision of a qualified physician.

Composition

• Active Ingredient:
  Methotrexate IP – 15 mg per tablet

• Excipients:
  q.s.

• Dosage Form:
  Tablet

• Pharmacopoeial Standard:
  IP

Uses / Indications

METHORA Methotrexate Tablets are indicated for:

• Rheumatoid arthritis and other autoimmune disorders

• Moderate to severe psoriasis

• Certain malignancies such as leukemia and lymphomas

• Other conditions as prescribed by a physician

(Prescription medicine – use under strict medical supervision)

Dosage & Administration

• Taken orally as prescribed by the physician

• Commonly administered once weekly for non-oncology indications

• Tablets should be swallowed whole with water

• Routine monitoring of blood counts, liver function, and kidney function is mandatory

Storage Instructions

• Store below 25°C

• Protect from moisture and light

• Keep out of reach of children

Atopica is indicated for the symptomatic treatment of chronic allergic dermatitis in cats, and treatment of chronic manifestations of atopic dermatitis in dogs.

are non-cyclooxygenase inhibiting non-steroidal anti-inflammatory drugs (NSAIDs) prescribed to manage pain and inflammation related to osteoarthritis (OA) in dogs, specifically targeting the EP4 receptor.

 is a prescription, single-tablet regimen (STR) used to treat HIV-1 in adults and children (weighing at least 25 kg). It combines four active ingredients—elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (TAF)—to reduce the amount of virus in the body and boost immune function. 

is a factory-calibrated Continuous Glucose Monitoring (CGM) system for individuals 2+ with diabetes, replacing daily fingersticks.

Evogen 100 IU by Alley is a synthetic growth hormone produced by recombinant DNA and is identical to the naturally occurring human growth hormone Somatropin.